“IN SILICO SCREENING OF EFAVIRENZ AND EFAVIRENZ NICOTINAMIDE COCRYSTAL FOR ITS ACTIVITY AGAINST HIV AND SARS COV-2”. 2024. Nirma University Journal of Pharmaceutical Sciences 10 (1): 71-86. https://doi.org/10.5281/.